Study Evaluating the Safety of Intranasal Administration of 400 μg of Fluticasone Propionate Twice a Day (BID) Using a Novel Bi-Directional Device in Subjects With Chronic Sinusitis With or Without Nasal Polyps
Clinical trial NCT01623323 · COMPLETED
Trial details
- NCT number
- NCT01623323
- Sponsor
- Optinose US Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-01
- Primary completion
- 2015-03-01
- Enrollment
- 705
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.